Primary outcomes by 1q21+ status for isatuximab-treated patients with relapsed/refractory multiple myeloma: subgroup analyses from ICARIA-MM and IKEMA
| Title: | Primary outcomes by 1q21+ status for isatuximab-treated patients with relapsed/refractory multiple myeloma: subgroup analyses from ICARIA-MM and IKEMA |
|---|---|
| Authors: | Tom Martin; Paul G Richardson; Thierry Facon; Philippe Moreau; Aurore Perrot; Ivan Spicka; Kamlesh Bisht; Marlene Inchauspé; France Casca; Sandrine Macé; Helgi van de Velde; Kenshi Suzuki |
| Source: | Haematologica, Vol 107, Iss 10 (2022) |
| Publisher Information: | Ferrata Storti Foundation, 2022. |
| Publication Year: | 2022 |
| Collection: | LCC:Diseases of the blood and blood-forming organs |
| Subject Terms: | Diseases of the blood and blood-forming organs; RC633-647.5 |
| Document Type: | article |
| File Description: | electronic resource |
| Language: | English |
| ISSN: | 0390-6078; 1592-8721 |
| Relation: | https://haematologica.org/article/view/10684; https://doaj.org/toc/0390-6078; https://doaj.org/toc/1592-8721 |
| DOI: | 10.3324/haematol.2022.280660 |
| Access URL: | https://doaj.org/article/ef5c6c0a96fa4f00a16ff07ee21c4c89 |
| Accession Number: | edsdoj.f5c6c0a96fa4f00a16ff07ee21c4c89 |
| Database: | Directory of Open Access Journals |